Patents by Inventor Nagjie Laila Alijaj

Nagjie Laila Alijaj has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PROSTATE CANCER CLINICAL STATUS MARKERS
    Publication number: 20250067741
    Abstract: The present invention relates to the field of assessment of the health status, particular with regard to prostate cancer risk, by measurement of certain proteins in human samples, in particular in human urine.
    Type: Application
    Filed: December 16, 2022
    Publication date: February 27, 2025
    Applicant: UNIVERSITÄT ZÜRICH
    Inventors: Irina BANZOLA, Blaz PAVLOVIC, Nagjie Laila ALIJAJ, Daniel EBERLI
  • Single Domain Antibodies and Their Use in Cancer Therapies
    Publication number: 20230302050
    Abstract: The present application relates to fully humanized anti-FGFR4 single domain antibodies (sdAbs) and variants thereof. The present invention further relates to functionalized drug nanocarriers, nucleic acids, vectors, host cells, immune cells comprising said sdAbs, and compositions comprising thereof, as well as their use for therapy.
    Type: Application
    Filed: May 20, 2021
    Publication date: September 28, 2023
    Applicants: Institut Curie, Centre National de la Recherche Scientifique, The University of Zurich, Honing Biosciences
    Inventors: Sandrine Moutel, Franck Perez, Michele Bernasconi, Nagjie Laila Alijaj, Zélia Gouveia